CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,764,000
- in 1 filing, $1.8M under 10b5-1 plans
Net −$1,764,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-14 | Grossman Adam S President,CEO, and Interim CFO | Other disposition | −460,000 | $3.21 | $1.5M | 2,191,475 |
| 2024-06-14 | Grossman Adam S President,CEO, and Interim CFO | Gift | −10,000 | 2,181,475 | ||
| 2024-06-14 | Grossman Adam S President,CEO, and Interim CFO | Sale | −100,000 | $10.72 | $1.1M | 2,081,475 |
| 2024-04-01 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Grant or award | +192,320 | 304,510 | ||
| 2024-04-01 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Grant or award · Stock Option (right to buy) | +300,328 | 300,328 | ||
| 2024-03-31 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Shares withheld for taxes | −2,085 | $6.60 | $14K | 112,190 |
| 2024-03-31 | Grossman Adam S President,CEO, and Interim CFO | Shares withheld for taxes | −21,752 | $6.60 | $144K | 2,651,475 |
| 2024-03-19 | ELMS STEVE Director | Sale | −411,829 | $6.08 | $2.5M | 2,115,671 |
| 2024-03-18 | ELMS STEVE Director | Sale | −49,887 | $6.01 | $300K | 2,527,500 |
| 2024-03-15 | ELMS STEVE Director | Sale | −183,008 | $6.01 | $1.1M | 2,577,387 |
| 2024-03-14 | ELMS STEVE Director | Sale | −448,276 | $6.05 | $2.7M | 2,760,395 |
| 2024-03-13 | ELMS STEVE Director | Sale | −407,000 | $6.21 | $2.5M | 3,208,671 |
| 2024-03-07 | LENZ BRIAN EVP, CFO | Shares withheld for taxes | −16,965 | $6.16 | $105K | 703,002 |
| 2024-03-07 | Grossman Adam S President and CEO | Shares withheld for taxes | −28,763 | $6.16 | $177K | 2,673,227 |
| 2024-03-06 | LENZ BRIAN EVP, CFO | Shares withheld for taxes | −16,677 | $6.12 | $102K | 719,967 |
| 2024-03-06 | Grossman Adam S President and CEO | Shares withheld for taxes | −55,003 | $6.12 | $337K | 2,701,990 |
| 2024-02-29 | Grossman Adam S President and CEO | Shares withheld for taxes | −9,588 | $5.36 | $51K | 2,756,993 |
| 2024-02-29 | LENZ BRIAN EVP, CFO | Shares withheld for taxes | −4,935 | $5.36 | $26K | 736,644 |
| 2024-02-26 | Grossman Adam S President and CEO | Grant or award | +557,728 | 2,766,581 | ||
| 2024-02-26 | Grossman Adam S President and CEO | Grant or award · Stock Option (right to buy) | +870,950 | 870,950 |
Page 12 of 31 · 618 trades